 |
|
|
| |
The Value of Increased HCV Testing and Treatment Strategies
in Spain to Achieve Elimination Goals - cost effectiveness analysis
|
| |
| |
EASL: Macroeconomic assessment of overall and per-patient healthcare costs of Hepatitis C-infected patients in an integrated health system in the era of direct-acting antiviral therapy - (07/11/22)
EASL: REAL-WORLD VALUE AND INNOVATION OF DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF CHRONIC HEPATITIS C AT Kaiser PERMANENTE SOUTHERN CALIFORNIA - (06/23/22)
EASL 2022 Jue 22-26 London
J. L. CALLEJA1, J. ESPIN2, A. KAUSHIK3, M. HERNANDEZ-GUERRA4, R. BLISSETT5, A.
IGLOI-NAGY5, A. YEHOSHUA3 1Hospital Universitario Puerta de Hierro, Universidad Autonoma de Madrid, Madrid, Spain
2Escuela Andaluza de Salud Pública, Granada, Spain
3Gilead Sciences, Inc., Foster City, CA, USA
4Hospital Universitario de Canarias, Tenerife, Spain
5Maple Health Group, New York City, NY, USA
|
| |
|
|
|
|
|
